PROSTATE CANCER RECURRENT
Clinical trials for PROSTATE CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER RECURRENT trials appear
Sign up with your email to follow new studies for PROSTATE CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to slow advanced prostate cancer
Disease control CompletedThis study tests whether adding an immunotherapy drug called lorigerlimab to standard chemotherapy (docetaxel) can help men with a tough-to-treat type of prostate cancer live longer without their disease getting worse. About 150 men with metastatic castration-resistant prostate c…
Matched conditions: PROSTATE CANCER RECURRENT
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New imaging combo could spot hidden prostate cancer recurrence
Diagnosis CompletedThis study tested whether two imaging methods—Histoscanning and multiparametric MRI—can accurately detect and locate prostate cancer that comes back after radiation therapy. Thirty men with rising PSA levels or biopsy-confirmed recurrence were enrolled. Each participant received …
Matched conditions: PROSTATE CANCER RECURRENT
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 26, 2026 13:17 UTC
-
AI learns from 14,000 prostate scans to spot aggressive cancers
Knowledge-focused CompletedThis study created a massive, secure database of over 14,000 prostate MRI scans from men with or suspected of having prostate cancer. Researchers used this data to train artificial intelligence (AI) models to better tell apart slow-growing from aggressive cancers, predict if canc…
Matched conditions: PROSTATE CANCER RECURRENT
Sponsor: Fondazione del Piemonte per l'Oncologia • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC